Prospective Post-market Data Collection for Ion Endoluminal System to Understand CT to Body Divergence
The goal of this study is to collect post-market data for the Ion Endoluminal System to understand CT to body divergence.
Checked against the public recordLast updated Aug 9, 2022 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Intuitive Surgical
- Interventions being studied
- Device: Ion Endoluminal System
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Age of 18 years or older * Undergoing a lung biopsy procedure with Ion System * Have peripheral pulmonary lesion (5th bronchial generation or higher) * Willingness to participate as demonstrated by signing the informed consent Exclusion Criteria: * Unable to provide informed consent * Presence of bilateral nodules intended to be biopsied during procedure * The presence of medical conditions contraindicating general anesthesia or bronchoscopic biopsy * Vulnerable population (e.g., prisoners, mentally disabled)
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- FirstHealth of the Carolinas Moore Regional HospitalPinehurst, North Carolina
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 9, 2022. Always confirm current availability with the study team.